Table 3.
Concentration of adipocytokines in the serum of patients without MetS depending on the number of MetS components, Me (Q1; Q3).
| Indicators | 0 MetS Components (n = 15) |
1 MetS Component (n = 24) |
2 MetS Components (n = 25) |
p-Value |
|---|---|---|---|---|
| Adiponectin, μg/mL | 12.33 (11.53; 21.38) |
10.11 (7.14; 13.69) |
8.37 (5.96; 14.66) |
p01 = 0.1456 p12 = 0.7441 p02 = 0.1113 |
| Leptin, pg/mL | 3.14 (1.01; 6.62) |
6.87 (2.48; 12.27) |
10.89 (3.52; 23.46) |
p01 = 0.0593 p12 = 0.5003 p02 = 0.0146 * |
| Leptin–adiponectin ratio | 0.25 (0.06; 0.52) |
0.96 (0.47; 2.28) |
1.48 (0.43; 3.29) |
p01 = 0.0147 * p12 = 0.6905 p02 = 0.0323 |
| TNF-α, pg/mL | 16.09 (10.11; 20.23) |
20.12 (13.20; 28.24) |
17.98 (13.13; 28.66) |
p01 = 0.0530 p12 = 0.6938 p02 = 0.1694 |
| IL-6, pg/mL | 4.99 (4.14; 7.26) |
5.52 (3.45; 12.23) |
5.15 (4.15; 7.24) |
p01 = 0.4529 p12 = 0.3770 p02 = 0.9523 |
Me (Q1;Q3), median (lower quartile; upper quartile); p01, comparison of patients with 0 and 1 MetS components; p12, comparison of patients with 1 and 2 MetS components; p02, comparison of patients with 0 and 2 MetS components. * Statistically significant difference according to the Mann–Whitney U test with Bonferroni correction for the three groups of comparisons.